Beijing accused the United States on Friday of employing "tariff pressure and blackmail" following President Donald Trump's decision to impose an additional 10% duty on imports from China. The fresh tariffs, in conjunction with a 10% duty from February 4, coincided with the kickoff of China's annual parliamentary meeting on Wednesday, during which Beijing is set to unveil its economic priorities for 2025.
The U.S. has been criticized for using the fentanyl issue as leverage for imposing tariffs, with the Chinese foreign ministry spokesperson highlighting the negative impact on drug control cooperation. Despite achievements in anti-drug collaboration, tensions escalated as Trump announced tariffs on Mexican and Canadian goods alongside the additional 10% duty on Chinese imports.
Amid the escalating trade conflict, China and the U.S. are at odds over fentanyl control, with Beijing emphasizing its strict anti-drug policies and citing risks to global supply chains from new tariffs. While analysts suggest China remains open to negotiation, the possibility of a trade deal is diminishing as both sides brace for prolonged economic strain.
As the dialogue remains stalled, uncertainties persist regarding the Trump administration's ultimate objectives in its dealings with China. While Beijing expresses a desire to resume negotiations swiftly, warnings of retaliatory actions loom if talks fail to materialize.
The ongoing trade tensions have set the stage for continued friction between the world's leading economies, with both sides fortifying their positions. China and the U.S. seem primed for protracted trade discord, as evidenced by recent policy moves and rhetoric from both nations.